Brief: Immunoscape And Mink Therapeutics Collaborate To Accelerate Novel Tcr Identification And Therapeutic Development
20/12/2023 12:32
Dec 20 (Reuters) - Mink Therapeutics Inc INKT.O :
* IMMUNOSCAPE AND MINK THERAPEUTICS COLLABORATE TO
ACCELERATE
NOVEL TCR IDENTIFICATION AND THERAPEUTIC DEVELOPMENT
* MINK THERAPEUTICS INC - DEVELOPMENT TO FOCUS ON NOVEL CELL
THERAPIES AS WELL AS BISPECIFIC IMMUNE CELL ENGAGERS AGAINST
SOLID TUMORS
Source text for Eikon: ID:nGNX2QCqsy
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's